Enhanced mRNA Expression of Colonic IL-6 in Cronkhite-Canada Syndrome Bearing Colorectal Cancer
In Vivo · 2026-05 · 40 (3) · 1810-1817
DOI: 10.21873/invivo.14334 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vivo, online erschienen am 28.04.2026. Verfasst von Daisuke Fujihara und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan. Hauptthemen laut MEDLINE: Interleukin-6, Colorectal Neoplasms, RNA, Messenger, Cronkhite-Canada Syndrome. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND/AIM: Immunosuppressive and nutritional treatments have improved the prognosis of Cronkhite-Canada syndrome (CCS). CCS-associated polyps are benign and categorized into hamartomatous, inflammatory, hyperplastic, and adenomatous polyps; however, the development of gastrointestinal cancer is considered the most significant prognostic factor for CCS. Although the adenoma-carcinoma sequence and inflammation-associated carcinogenesis are two major pathways for the development of colorectal cancers (CRCs), it remains largely unknown which pathway plays critical roles in the development of CRCs in CCS. Inflammation-associated carcinogenesis might be involved in the development of CRCs associated with CCS because CCS-associated polyps are characterized by submucosal infiltration of immune cells. Given the fact that proinflammatory cytokines including interleukin (IL)-6, IL-1β, and tumor necrosis factor (TNF)-α underlie the pathogenesis of inflammation-associated carcinogenesis, we examined the involvement of proinflammatory cytokines in the transformation of CCS-associated polyps into CRCs. PATIENTS AND METHODS: Three cases of CCS were enrolled: two cases with concurrent CRCs and a single case without CRC. mRNA was isolated from non-cancerous CCS-associated polyps and subjected to reverse transcription quantitative polymerase chain reaction to determine expression of proinflammatory cytokines. Colonic biopsy samples were isolated from non-tumor portions of patients with colonic adenoma to determine mRNA expression of proinflammatory cytokines in healthy colonic mucosa. RESULTS: , in non-cancerous CCS-associated polyps was observed in two patients with CCS and concurrent CRCs as compared with four healthy colonic mucosal samples and a patient with CCS without CRC. CONCLUSION: IL-6-mediated inflammation-associated carcinogenesis might be involved in the transformation of CCS-associated polyps into CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan.
- Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan tomohiro@med.kindai.ac.jp.
Zitieren
APA
Fujihara, D., Honjo, H., Masuta, Y., Otsuka, Y., Masaki, S., Minaga, K., Kamata, K., Tsuji, N., Watanabe, T., & Kudo, M. (2026). Enhanced mRNA Expression of Colonic IL-6 in Cronkhite-Canada Syndrome Bearing Colorectal Cancer. In Vivo, 40(3), 1810-1817. https://doi.org/10.21873/invivo.14334
Vancouver
Fujihara D, Honjo H, Masuta Y, Otsuka Y, Masaki S, Minaga K, et al. Enhanced mRNA Expression of Colonic IL-6 in Cronkhite-Canada Syndrome Bearing Colorectal Cancer. In Vivo. 2026;40(3):1810-1817. doi:10.21873/invivo.14334
BibTeX
@article{Fujihara2026,
author = {Fujihara, Daisuke and Honjo, Hajime and Masuta, Yasuhiro and Otsuka, Yasuo and Masaki, Sho and Minaga, Kosuke and Kamata, Ken and Tsuji, Naoko and Watanabe, Tomohiro and Kudo, Masatoshi},
title = {Enhanced mRNA Expression of Colonic IL-6 in Cronkhite-Canada Syndrome Bearing Colorectal Cancer},
journal = {In Vivo},
year = {2026},
volume = {40},
number = {3},
pages = {1810--1817},
doi = {10.21873/invivo.14334}
}
EUVIMED